Yaodong Li, Yangxin Chen, Jingfeng Wang, Jian Xu, Ruogu Li, Zhaohui Qiu, Lingyun Jiang, Farong Shen, Shubin Jiang, Bin Li, Yingjie Chu, Lang He, Lijin Pu, Xuebin Han, Xianping Long, Xiaolin Xue, Jianhong Tao, Yongquan Wu, Tao Guo, Yiqiang Yuan, Xianqing Wang, Jiang Wang, Jing Xu, Yujie Zhao, Zhihui Zhang, Wei Hua, Yangang Su, Baopeng Tang
BACKGROUND International studies have shown that use of a subcutaneous implantable cardioverter defibrillator (S-ICD) could reduce lead-related complications while maintaining adequate defibrillation performance; however, data from the Chinese population or other Asian groups are limited. MATERIAL AND METHODS SCOPE is a prospective, multicenter, observational cohort study. Two hundred patients with primary prevention indication for sudden cardiac death (SCD), who are candidates for S-ICD, will be enrolled. From the same population, another 200 patients who are candidates for transvenous implantable cardioverter defibrillator (TV-ICD) will be enrolled after being matched for age, sex, SCD high-risk etiology (ischemic cardiomyopathy, and non-ischemic cardiomyopathy, ion channel disease, and other) and atrial fibrillation in a 1: 1 ratio with enrolled S-ICD patients...
February 24, 2024: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research